Piazza P V, Le Moal M L
Psychobiologie des Comportements Adaptifs, INSERM U259, Université de Bordeaux II, France.
Annu Rev Pharmacol Toxicol. 1996;36:359-78. doi: 10.1146/annurev.pa.36.040196.002043.
Research on drug abuse has recently focused on understanding the vulnerability to develop addiction that is present in certain individuals. These investigations suggest that addiction results from an interaction between drugs and specific individual substrates. Differences in the propensity to develop drug intake can be demonstrated in animals with equal access to drugs under stable laboratory conditions and can be predicted by drug-independent behaviors. Stress, corticosterone, and mesencephalic dopaminergic neurons seem to be organized in a pathophysiological chain determining such a vulnerability. An increased corticosterone secretion, or a higher sensitivity to the effects of this hormone, either naturally present in certain individuals or induced by stress in others, increases the vulnerability to develop drug intake, via an enhancement of the activity of mesencephalic dopaminergic neurons. These findings suggest that addiction therapies should counteract the biological peculiarity that leads some individuals to respond in a pathophysiological way to drugs.
近期,药物滥用研究聚焦于了解某些个体中存在的成瘾易感性。这些研究表明,成瘾是药物与特定个体底物相互作用的结果。在稳定实验室条件下,给予同等获取药物机会的动物中,可证明药物摄入倾向存在差异,且可通过与药物无关的行为进行预测。应激、皮质酮和中脑多巴胺能神经元似乎在决定这种易感性的病理生理链中相互关联。皮质酮分泌增加,或对该激素作用的更高敏感性,无论是某些个体天然存在的,还是其他个体因应激诱导产生的,都会通过增强中脑多巴胺能神经元的活性,增加药物摄入的易感性。这些发现表明,成瘾治疗应抵消导致一些个体对药物产生病理生理反应的生物学特性。